Item 5.03 Amendments to Articles of Incorporation or Bylaws: Change in Fiscal
On December 27, 2018, Harrow Health, Inc. (formerly, Imprimis Pharmaceuticals,
Inc.) (the "Company") amended its restated certificate of incorporation
("Amendment") to change its corporate name from "Imprimis Pharmaceuticals, Inc."
to "Harrow Health, Inc."
The name change was previously approved by the Board of Directors. The
shareholders, under Delaware General Corporation Law, were not required to
approve the name change.
The stockholders do not need to take any action as a result of the name change,
including that there is no need to exchange their certificates representing
their shares of common stock. The current stock certificate will continue to
represent their ownership interest in the Company. Stockholders, however, may
return their certificates to the transfer agent for the Company and obtain an
A copy of the Amendment is filed as Exhibit 3.1 to this Current Report on Form
The press release relating to the name change being completed and reflected on
The NASDAQ Capital Market is being furnished as Exhibit 99.1 to this Current
Report on Form 8-K.
Item 8.01 Other Events
The trading symbol reflecting the new name for the company, for the common stock
of the Company, on The NASDAQ Capital Market is HROW.
Item 9.01. Financial Statements and Exhibits
3.1 Amendment to the Restated Certificate of Incorporation for the name
change, filed as of December 27, 2018
99.1 Press Release issued by Harrow Health, Inc. on December 31, 2018
© Edgar Online, source Glimpses